Working… Menu

A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03531892
Recruitment Status : Active, not recruiting
First Posted : May 22, 2018
Last Update Posted : May 19, 2021
Kissei Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Eisai Inc. ( EA Pharma Co., Ltd. )

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 16, 2020
Estimated Study Completion Date : March 31, 2023